Local thermal ablative therapies for extracranial oligometastatic disease of non-small-cell lung cancer

被引:2
|
作者
Kong, Yongmei [1 ,2 ,3 ]
Xu, Hui [1 ,2 ,3 ]
Huang, Yahan [1 ,2 ,3 ]
Wei, Zhigang [1 ,2 ]
Ye, Xin [1 ,2 ]
机构
[1] Shandong First Med Univ, Affiliated Hosp 1, Dept Oncol, Jinan 250000, Shandong, Peoples R China
[2] Shandong Prov Qianfoshan Hosp, Shandong Lung Canc Inst, Shandong Key Lab Rheumat Dis & Translat Med, Jinan 250000, Shandong, Peoples R China
[3] Shandong First Med Univ, Jinan, Peoples R China
基金
中国国家自然科学基金;
关键词
extracranial; non-small cell lung cancer; oligometastatic diseases; thermal ablation; RADIOFREQUENCY ABLATION; MICROWAVE ABLATION; CLASSIFICATION; RADIOTHERAPY; METASTASIS; OUTCOMES; TUMOR; CHEMOTHERAPY; METAANALYSIS; MULTICENTER;
D O I
10.1111/ajco.13766
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Non-small cell lung cancer (NSCLC) is the most common type of lung cancer. Clinically, 40-50% of patients with NSCLC are found to have systemic metastasis at the initial diagnosis. Meanwhile, 30-75% of patients with lung cancer who have undergone radical surgical resection have local recurrence and distant metastases. However, not all distant metastases are multiple, and some are potentially curable. In this study, among the patients with NSCLC having distant organ metastasis, approximately 7% showed extrapulmonary solitary metastasis and remained in this relatively stable state for a long time. This form of metastasis is known as NSCLC oligometastases. This review describes the concept and classification of oligometastases, as well as the local treatment and prognosis of extracranial oligometastases.
引用
收藏
页码:3 / 8
页数:6
相关论文
共 50 条
  • [41] Review of the current targeted therapies for non-small-cell lung cancer
    Nguyen, Kim-Son H.
    Neal, Joel W.
    Wakelee, Heather
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2014, 5 (04): : 576 - 587
  • [42] Personalized choice of maintenance therapies in non-small-cell lung cancer
    Blais, N.
    Corrales-Rodriguez, L.
    CURRENT ONCOLOGY, 2012, 19 : S64 - S72
  • [43] Current state of vaccine therapies in non-small-cell lung cancer
    Romero, Pedro
    CLINICAL LUNG CANCER, 2008, 9 : S28 - S36
  • [44] Emerging Targeted Therapies in Non-Small-Cell Lung Cancer (NSCLC)
    Mina, Syeda A.
    Shanshal, Mohamed
    Leventakos, Konstantinos
    Parikh, Kaushal
    CANCERS, 2025, 17 (03)
  • [45] Novel Therapies for Non-Small-Cell Lung Cancer: A 2008 Update
    Bunn, Paul A., Jr.
    CLINICAL LUNG CANCER, 2009, 10 : S6 - S6
  • [46] Targeted therapies and non-small-cell lung cancer: new developments
    Gridelli, Cesare
    CURRENT OPINION IN ONCOLOGY, 2007, 19 (02) : 75 - 77
  • [47] Targeted therapies in non-small-cell lung cancer: A paradigm in evolution
    Sangha, Randeep
    Lara, Primo N., Jr.
    Mack, Philip
    Gandara, David R.
    CLINICAL LUNG CANCER, 2008, 9 : S90 - S91
  • [48] Emerging Targeted Therapies in Advanced Non-Small-Cell Lung Cancer
    Li, Shenduo
    Correia, Guilherme Sacchi de Camargo
    Wang, Jing
    Manochakian, Rami
    Zhao, Yujie
    Lou, Yanyan
    CANCERS, 2023, 15 (11)
  • [49] Targeted therapies and non-small-cell lung cancer: work in progress?
    Gridelli, C
    CURRENT OPINION IN ONCOLOGY, 2006, 18 (02) : 132 - 134
  • [50] The role of surgery in integrated therapies for non-small-cell lung cancer
    Sartori, F
    Bortolotti, L
    Michelon, M
    Colaut, F
    Loy, M
    Rea, F
    Favaretto, A
    ANNALS OF ONCOLOGY, 1999, 10 : 73 - 76